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Background:  Recent data suggest that compared with 300-mg, a 600-mg loading dose of clopidogrel results in a higher and more rapid 
antiplatelet effect, which would decrease distal embolization and periprocedural ischemia and would protect microcirculation during primary 
percutaneous coronary intervention (PCI), which in turn would reduce myocardial infarct size. We sought to determine whether a 600-mg loading 
dose of clopidogrel reduces myocardial infarct size compared with a 300-mg using contrast-enhanced magnetic resonance imaging (MRI) in 
patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI).
Methods:  In 198 patients undergoing primary PCI for STEMI, MRI was performed a median of 7 days after the index event. The primary end point 
was myocardial infarct size as assessed by MRI.
Results:  Baseline characteristics were not significantly different between the 600-mg clopidogrel loading group (n=117) and the 300-mg group 
(n=81). The median infarct size was significantly smaller in the 600-mg group than in the 300-mg group (17.3% [8.9-26.2] versus 21.7% [12.9-
30.0], p=0.03). Patients in the 600-mg group also had a significantly lower extent of microvascular obstruction and infarct transmurality than did 
those in the 300-mg group (0.9% [0-2.2] versus 1.5% [0-3.9], p=0.049 and 74.5% [61.7-83.9] versus 78.3% [68.9-86.7], p=0.04, respectively). 
After multivariate analysis, anterior infarction (OR 1.98, 95% CI 1.07-3.67, p=0.03) and angiographic no-reflow (OR 3.00, 95% CI 1.05-8.52, 
p=0.04) were independently predictive of a large infarct (infarct size>median 18.5%). A 600-mg clopidogrel loading dose showed a significant 
protective effect (OR 0.53, 95% CI 0.29-0.98, p=0.04).
Conclusions:  In patients undergoing primary PCI for STEMI, a 600-mg loading dose of clopidogrel reduced myocardial infarct size measured by 
MRI compared with a 300-mg loading dose.
